Aminosin Plus Injection
L-Leucine 620mg · L-Isoleucine 510mg +13 more
Injections · Prescription medication · Combination
Korea Pharmaceutical Industries Co., Ltd.
MFDS item code 202200749 · Approved 2022.02.17
Amino acid supplementation in patients for whom oral or gastrointestinal nutritional support is difficult
This medication is used to supplement necessary amino acids for patients who are unable to receive nutrition orally or through the gastrointestinal tract, or when such supply is insufficient. It helps improve the patient's nutritional status and aids recovery.
The intravenous dose depends on the patient's clinical condition and requirements for amino acids, electrolytes, and fluids (nutritional status and/or the degree of nitrogen catabolism due to disease). ○ Daily dose: For adults, the reference dose is 0.8g of amino acids per kg of body weight per day (equivalent to 9.5mL of this drug). Administer at least 180kcal of nonprotein energy source per 1g of nitrogen. Adjust the dose and infusion rate as appropriate according to the patient's age, weight, and clinical condition. Administer by intravenous infusion into a central vein. This drug should be administered with glucose or another source sufficient to provide adequate calories for parenteral nutrition.
For infants, the reference daily dose is 2.2g of amino acids per kg of body weight (equivalent to 26mL of this drug).
This medication must be used strictly according to a physician's instructions and should not be used arbitrarily without a prescription. It should not be administered to patients with allergic reactions to its components, those with severely impaired liver function, or patients with severe kidney disease. Use should also be avoided in patients with congenital amino acid metabolism disorders or those with heart failure, pulmonary edema, or oliguria. Particular caution is needed for specific patient groups, such as those with severe dehydration or electrolyte imbalances, and for those with impaired liver or kidney function. Dosage should be adjusted based on the patient's condition. During the administration of this medication, severe side effects such as allergic reactions or anaphylaxis may occur, so careful monitoring is necessary. During non-oral nutrition therapy, blood ammonia levels may rise, necessitating regular blood tests to monitor the condition. If any abnormal symptoms occur, administration should be stopped immediately. Additionally, electrolyte concentrations, blood glucose, fluid balance, and liver and kidney function should be regularly assessed to ensure they remain normal. This medication should be administered alongside appropriate energy sources, and particularly when combined with glucose, blood sugar and urine glucose levels should be carefully monitored. In the case of overdose, issues such as increased blood volume, electrolyte imbalance, and acidosis may arise, so the infusion rate should be adjusted and stopped immediately if abnormal symptoms occur. The safety of this medication has not been fully established for pregnant or breastfeeding women, and it should only be used when the therapeutic benefits outweigh the risks. In the case of children and the elderly, special caution is needed as physiological functions may differ; particularly in infants under 2 years old, administration should be done carefully while maintaining a shaded condition. This medication is for single use only; it should be used immediately after opening and any remaining contents should be discarded. When storing, avoid direct sunlight and keep at room temperature. Do not use if the contents are discolored or cloudy, or if the packaging is damaged. Finally, maintain strict aseptic conditions while preparing and administering this medication to reduce the risk of infection.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to protect it from air and moisture. A cool place between 1 and 25 degrees Celsius is suitable for storage. Take care not to place it in excessively hot or cold areas.
A colorless or pale yellow transparent liquid in a colorless transparent glass vial.
200 milliliters/vial, 250 milliliters/vial
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Leucine 620mg · L-Isoleucine 510mg +13 more
Injections · Prescription medication · Combination
Korea Pharmaceutical Industries Co., Ltd.
L-Serine 5g · L-Isoleucine 6g +13 more
Injections · Prescription medication · Combination
HK Innoen Co., Ltd.
L-Serine 4.25g · L-Isoleucine 5.1g +13 more
Injections · Prescription medication · Combination
HK Innoen Co., Ltd.
L-Leucine 402mg · L-Isoleucine 330mg +13 more
Injections · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.